Global Peripheral Nerve Stimulators (PNS) Market Outlook 2019-2023 - PNS Manufacturers Consistently Focusing on Innovating Products & Technologies to Enhance Their Device Capabilities - ResearchAndMarkets.com

DUBLIN--()--The "Global Peripheral Nerve Stimulators Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

The peripheral nerve stimulators market will register a CAGR of over 5% by 2023.

The high demand for peripheral nerve simulators over oral medications is expected to trigger the market growth during the forecast period.

These simulators reduce or eliminate the use of narcotic drugs. They also allow pain relief by offering target specific treatment in patients with refractory or chronic pain conditions, including complex regional pain syndrome, and cranial neuralgias. Thus, rising demand for peripheral nerve simulators over conventional oral medications will drive the market growth during the forecast period.

Increasing aging population and rising nerve injury cases

The growing older population and rising nerve injury cases are expected to drive the global peripheral nerve stimulators market during the forecast period.

Complications associated with peripheral nerve stimulators

Complications associated with the use of peripheral nerve stimulators include infection, pain, bleeding, allergic reaction, difficulties in relieving pain in large nerve gaps, chances of failure to relieve pain or increase pain, hematoma, and blunt or sharp nerve trauma.

Competitive Landscape

The market appears to be moderately fragmented. PNS manufacturers consistently focusing on innovating products and technologies to enhance their device capabilities, thereby increasing product sales and revenue outcomes.

This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

Key Players

  • Abbott
  • Avanos Corporate
  • B. Braun Melsungen AG
  • Boston Scientific Corp.
  • Medtronic
  • SPR Therapeutics Inc.

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Comparison by product
  • Transcutaneous - Market size and forecast 2018-2023
  • Percutaneous - Market size and forecast 2018-2023
  • Implantable - Market size and forecast 2018-2023
  • Market opportunity by product

PART 07: MARKET SEGMENTATION BY STIMULATING FEATURE

  • Comparison by stimulating feature
  • PNS-TOF - Market size and forecast 2018-2023
  • PNS - Market size and forecast 2018-2023
  • Market opportunity by stimulating feature

PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE

  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • RoW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

PART 12: MARKET TRENDS

  • Technological advances
  • Wireless PNS
  • Industry developments

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott
  • Avanos Corporate
  • B. Braun Melsungen AG
  • Boston Scientific Corp.
  • Medtronic
  • SPR Therapeutics Inc.

For more information about this report visit https://www.researchandmarkets.com/r/9qun14

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Neurology Devices

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Neurology Devices